5920 GENES FOUND

? »

Limit search: Genes with antibodies | Premium | Premium (Tissue) | Premium (Subcell) | Premium (Cell line)

« prev | Page of 119 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ADAM32ADAM metallopeptidase domain 32Enzymes
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
ADAM33ADAM metallopeptidase domain 33Disease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Mixed
ADAM7ADAM metallopeptidase domain 7Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Predicted secreted proteins
Not detected
ADAM8ADAM metallopeptidase domain 8CD markers
Enzymes
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
ADAM9ADAM metallopeptidase domain 9Cancer-related genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
ADAMTS1ADAM metallopeptidase with thrombospondin type 1 motif, 1Cancer-related genes
Enzymes
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
ADAMTS4ADAM metallopeptidase with thrombospondin type 1 motif, 4Cancer-related genes
Enzymes
Tissue enhanced
ADAP1ArfGAP with dual PH domains 1
Mixed
ADCK2AarF domain containing kinase 2Enzymes
Predicted membrane proteins
Expressed in all
ADCK4AarF domain containing kinase 4Disease related genes
Enzymes
Potential drug targets
Expressed in all
ADCK5AarF domain containing kinase 5Enzymes
Predicted membrane proteins
Expressed in all
ADCY1Adenylate cyclase 1 (brain)Cancer-related genes
Enzymes
Predicted membrane proteins
Tissue enriched
ADCY10Adenylate cyclase 10 (soluble)Cytoskeleton related proteins
Disease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Tissue enriched
ADCY2Adenylate cyclase 2 (brain)Enzymes
Predicted membrane proteins
Tissue enhanced
ADCY3Adenylate cyclase 3Enzymes
Plasma proteins
Predicted membrane proteins
Expressed in all
ADCY4Adenylate cyclase 4Enzymes
Plasma proteins
Predicted membrane proteins
Expressed in all
ADCY5Adenylate cyclase 5Disease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Tissue enhanced
ADCY6Adenylate cyclase 6Enzymes
Predicted membrane proteins
Expressed in all
ADCY7Adenylate cyclase 7Enzymes
Predicted membrane proteins
Expressed in all
ADCY8Adenylate cyclase 8 (brain)Enzymes
Predicted membrane proteins
Group enriched
ADCY9Adenylate cyclase 9Enzymes
Predicted membrane proteins
Expressed in all
ADCYAP1R1Adenylate cyclase activating polypeptide 1 (pituitary) receptor type IG-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Transporters
Tissue enhanced
ADGBAndroglobinEnzymes
Group enriched
ADIGAdipogeninPredicted membrane proteins
Predicted secreted proteins
Tissue enriched
ADIPOR1Adiponectin receptor 1Predicted membrane proteins
Expressed in all
ADIPOR2Adiponectin receptor 2Predicted membrane proteins
Expressed in all
ADORA1Adenosine A1 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
ADORA2AAdenosine A2a receptorCancer-related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
ADORA2BAdenosine A2b receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
ADORA3Adenosine A3 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
ADPGKADP-dependent glucokinaseEnzymes
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
ADPRMADP-ribose/CDP-alcohol diphosphatase, manganese-dependentEnzymes
Predicted membrane proteins
Expressed in all
ADRA1AAdrenoceptor alpha 1AFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
ADRA1BAdrenoceptor alpha 1BCancer-related genes
FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Tissue enhanced
ADRA1DAdrenoceptor alpha 1DFDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Tissue enhanced
ADRA2AAdrenoceptor alpha 2AFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
ADRA2BAdrenoceptor alpha 2BFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
ADRA2CAdrenoceptor alpha 2CFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
ADRB1Adrenoceptor beta 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
ADRB2Adrenoceptor beta 2, surfaceFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Mixed
ADRB3Adrenoceptor beta 3FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
ADSSL1Adenylosuccinate synthase like 1Enzymes
Plasma proteins
Tissue enriched
ADTRPAndrogen-dependent TFPI-regulating proteinPredicted membrane proteins
Tissue enhanced
AE000662.92Uncharacterized protein Predicted membrane proteins
Not detected
AF196779.12WD repeat domain phosphoinositide-interacting protein 4 Predicted membrane proteins
Not detected
AFG3L2AFG3-like AAA ATPase 2Disease related genes
Enzymes
Mitochondrial proteins
Plasma proteins
Potential drug targets
Predicted membrane proteins
Expressed in all
AGBL1ATP/GTP binding protein-like 1Disease related genes
Enzymes
Potential drug targets
Tissue enhanced
AGERAdvanced glycosylation end product-specific receptorCancer-related genes
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enriched
AGMOAlkylglycerol monooxygenaseEnzymes
Predicted membrane proteins
Tissue enhanced
AGPAT11-acylglycerol-3-phosphate O-acyltransferase 1Enzymes
Predicted membrane proteins
Expressed in all

« prev | Page of 119 | next »